Literature DB >> 15026495

Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's disease.

V Di Lazzaro1, A Oliviero, F Pilato, E Saturno, M Dileone, C Marra, A Daniele, S Ghirlanda, G Gainotti, P A Tonali.   

Abstract

OBJECTIVES: Recent transcranial magnetic stimulation (TMS) studies demonstrate that motor cortex excitability is increased in Alzheimer's disease (AD) and that intracortical inhibitory phenomena are impaired. The aim of the present study was to determine whether hyperexcitability is due to the impairment of intracortical inhibitory circuits or to an independent abnormality of excitatory circuits.
METHODS: We assessed the excitability of the motor cortex with TMS in 28 patients with AD using several TMS paradigms and compared the data of cortical excitability (evaluated by measuring resting motor threshold) with the amount of motor cortex disinhibition as evaluated using the test for motor cortex cholinergic inhibition (short latency afferent inhibition) and GABAergic inhibition (short latency intracortical inhibition). The data in AD patients were also compared with that from 12 age matched healthy individuals.
RESULTS: The mean resting motor threshold was significantly lower in AD patients than in controls. The amount of short latency afferent inhibition was significantly smaller in AD patients than in normal controls. There was also a tendency for AD patients to have less pronounced short latency intracortical inhibition than controls, but this difference was not significant. There was no correlation between resting motor threshold and measures of either short latency afferent or intracortical inhibition (r = -0.19 and 0.18 respectively, NS). In 14 AD patients the electrophysiological study was repeated after a single oral dose of the cholinesterase inhibitor rivastigmine. Resting motor threshold was not significantly modified by the administration of rivastigmine. In contrast, short latency afferent inhibition from the median nerve was significantly increased by the administration of rivastigmine.
CONCLUSIONS: The change in threshold did not seem to correlate with dysfunction of inhibitory intracortical cholinergic and GABAergic circuits, nor with the central cholinergic activity. We propose that the hyperexcitability of the motor cortex is caused by an abnormality of intracortical excitatory circuits.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15026495      PMCID: PMC1739006          DOI: 10.1136/jnnp.2003.018127

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  31 in total

1.  Implantation metastasis of pineoblastoma after stereotactic biopsy. Case report.

Authors:  J V Rosenfeld; M A Murphy; C W Chow
Journal:  J Neurosurg       Date:  1990-08       Impact factor: 5.115

Review 2.  Pancytopaenia from a disseminated anaplastic oligodendroglioma.

Authors:  T P Dawson
Journal:  Neuropathol Appl Neurobiol       Date:  1997-12       Impact factor: 8.090

3.  Magnetic stimulation in Alzheimer's disease.

Authors:  M de Carvalho; A de Mendonça; P C Miranda; C Garcia; M L Luís
Journal:  J Neurol       Date:  1997-05       Impact factor: 4.849

4.  Corticocortical inhibition in human motor cortex.

Authors:  T Kujirai; M D Caramia; J C Rothwell; B L Day; P D Thompson; A Ferbert; S Wroe; P Asselman; C D Marsden
Journal:  J Physiol       Date:  1993-11       Impact factor: 5.182

5.  Metastatic astrocytoma.

Authors:  J M Dewar; P J Dady; V Balakrishnan
Journal:  Aust N Z J Med       Date:  1985-12

6.  Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.

Authors:  B Moghaddam; B Adams; A Verma; D Daly
Journal:  J Neurosci       Date:  1997-04-15       Impact factor: 6.167

7.  Effects of voluntary contraction on descending volleys evoked by transcranial stimulation in conscious humans.

Authors:  V Di Lazzaro; D Restuccia; A Oliviero; P Profice; L Ferrara; A Insola; P Mazzone; P Tonali; J C Rothwell
Journal:  J Physiol       Date:  1998-04-15       Impact factor: 5.182

8.  The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery.

Authors:  G A Carlesimo; C Caltagirone; G Gainotti
Journal:  Eur Neurol       Date:  1996       Impact factor: 1.710

9.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

10.  Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study.

Authors:  U Ziemann; S Lönnecker; B J Steinhoff; W Paulus
Journal:  Ann Neurol       Date:  1996-09       Impact factor: 10.422

View more
  87 in total

1.  Cognitive function and cholinergic transmission in patients with subcortical vascular dementia and microbleeds: a TMS study.

Authors:  Raffaele Nardone; Pierpaolo De Blasi; Martin Seidl; Yvonne Höller; Francesca Caleri; Frediano Tezzon; Gunther Ladurner; Stefan Golaszewski; Eugen Trinka
Journal:  J Neural Transm (Vienna)       Date:  2011-04-24       Impact factor: 3.575

Review 2.  Noninvasive brain stimulation in Alzheimer's disease: systematic review and perspectives for the future.

Authors:  Catarina Freitas; Helena Mondragón-Llorca; Alvaro Pascual-Leone
Journal:  Exp Gerontol       Date:  2011-04-14       Impact factor: 4.032

3.  Cerebrospinal fluid levels of Aβ42 relationship with cholinergic cortical activity in Alzheimer's disease patients.

Authors:  Alessandro Martorana; Zaira Esposito; Francesco Di Lorenzo; Viola Giacobbe; Giulia Maria Sancesario; Giulia Bucchi; Sonia Bonnì; Sergio Bernardini; Roberto Sorge; Giuseppe Sancesario; Giorgio Bernardi; Carlo Caltagirone; Giacomo Koch
Journal:  J Neural Transm (Vienna)       Date:  2012-03-09       Impact factor: 3.575

4.  Reduced interhemispheric inhibition in mild cognitive impairment.

Authors:  Ryosuke Tsutsumi; Ritsuko Hanajima; Masashi Hamada; Yuichiro Shirota; Hideyuki Matsumoto; Yasuo Terao; Shinya Ohminami; Yoshihiro Yamakawa; Hiroyuki Shimada; Shoji Tsuji; Yoshikazu Ugawa
Journal:  Exp Brain Res       Date:  2012-01-11       Impact factor: 1.972

5.  Stability of clinical condition in mild cognitive impairment is related to cortical sources of alpha rhythms: an electroencephalographic study.

Authors:  Claudio Babiloni; Giovanni B Frisoni; Fabrizio Vecchio; Roberta Lizio; Michela Pievani; Geroldi Cristina; Claudia Fracassi; Fabrizio Vernieri; Guido Rodriguez; Flavio Nobili; Raffaele Ferri; Paolo M Rossini
Journal:  Hum Brain Mapp       Date:  2010-12-22       Impact factor: 5.038

6.  Effects of lorazepam on short latency afferent inhibition and short latency intracortical inhibition in humans.

Authors:  V Di Lazzaro; A Oliviero; E Saturno; M Dileone; F Pilato; R Nardone; F Ranieri; G Musumeci; T Fiorilla; P Tonali
Journal:  J Physiol       Date:  2005-02-17       Impact factor: 5.182

7.  Repetitive transcranial magnetic stimulation (rTMS) combined with cognitive training is a safe and effective modality for the treatment of Alzheimer's disease: clinical experience.

Authors:  Jose Martin Rabey; Evgenia Dobronevsky
Journal:  J Neural Transm (Vienna)       Date:  2016-09-08       Impact factor: 3.575

8.  Somatosensory responses in normal aging, mild cognitive impairment, and Alzheimer's disease.

Authors:  Julia M Stephen; Rebecca Montaño; Christopher H Donahue; John C Adair; Janice Knoefel; Clifford Qualls; Blaine Hart; Doug Ranken; Cheryl J Aine
Journal:  J Neural Transm (Vienna)       Date:  2009-12-15       Impact factor: 3.575

9.  Cholinergic dysfunction and amnesia in patients with Wernicke-Korsakoff syndrome: a transcranial magnetic stimulation study.

Authors:  Raffaele Nardone; Jürgen Bergmann; Pierpaolo De Blasi; Martin Kronbichler; Jörg Kraus; Francesca Caleri; Frediano Tezzon; Gunther Ladurner; Stefan Golaszewski
Journal:  J Neural Transm (Vienna)       Date:  2009-12-04       Impact factor: 3.575

10.  Functional evaluation of central cholinergic circuits in patients with Parkinson's disease and REM sleep behavior disorder: a TMS study.

Authors:  Raffaele Nardone; Jürgen Bergmann; Francesco Brigo; Monica Christova; Alexander Kunz; Martin Seidl; Frediano Tezzon; Eugen Trinka; Stefan Golaszewski
Journal:  J Neural Transm (Vienna)       Date:  2012-08-19       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.